Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacotherapy of scleritis: current paradigms and future directions
Robert M. Beardsley, Eric B. Suhler, James T. Rosenbaum, et al.
Expert Opinion on Pharmacotherapy (2013) Vol. 14, Iss. 4, pp. 411-424
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Rituximab Therapy for Refractory Scleritis
Eric B. Suhler, Lyndell L. Lim, Robert M. Beardsley, et al.
Ophthalmology (2014) Vol. 121, Iss. 10, pp. 1885-1891
Closed Access | Times Cited: 84
Treatment and management of scleral disorders
J. Daniel Diaz, Ethan K. Sobol, David C. Gritz
Survey of Ophthalmology (2016) Vol. 61, Iss. 6, pp. 702-717
Closed Access | Times Cited: 57
Current insights in the pathogenesis of scleritis
Daphne P. C. Vergouwen, Aniki Rothová, Josianne C. ten Berge, et al.
Experimental Eye Research (2020) Vol. 197, pp. 108078-108078
Open Access | Times Cited: 46
Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population‐Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune‐Mediated Inflammatory Disease
Tasanee Braithwaite, Nicola J. Adderley, Anuradhaa Subramanian, et al.
Arthritis & Rheumatology (2021) Vol. 73, Iss. 7, pp. 1267-1276
Open Access | Times Cited: 38
The clinical and pathogenic spectrum of surgically-induced scleral necrosis: A review
Raul E. Ruiz‐Lozano, Lucas A. Garza‐Garza, Osvaldo Davila‐Cavazos, et al.
Survey of Ophthalmology (2021) Vol. 66, Iss. 4, pp. 594-611
Closed Access | Times Cited: 34
Hyaluronic acid – PVA films for the simultaneous delivery of dexamethasone and levofloxacin to ocular tissues
Martina Ghezzi, Ilaria Ferraboschi, Adriana Fantini, et al.
International Journal of Pharmaceutics (2023) Vol. 638, pp. 122911-122911
Closed Access | Times Cited: 15
Biologic therapy for refractory scleritis: a new treatment perspective
Tania Fidelix, Luís Antônio Vieira, Denise de Freitas, et al.
International Ophthalmology (2015) Vol. 35, Iss. 6, pp. 903-912
Closed Access | Times Cited: 46
Rituximab in the Treatment of Refractory Noninfectious Scleritis
Jennifer H. Cao, Merih Oray, Lidia Cocho, et al.
American Journal of Ophthalmology (2016) Vol. 164, pp. 22-28
Closed Access | Times Cited: 46
Clinical Features and Complications of Scleritis in Chinese Patients
Peizeng Yang, Zi Ye, Jihong Tang, et al.
Ocular Immunology and Inflammation (2016) Vol. 26, Iss. 3, pp. 387-396
Closed Access | Times Cited: 45
Uveitis
James P. Dunn
Primary Care Clinics in Office Practice (2015) Vol. 42, Iss. 3, pp. 305-323
Closed Access | Times Cited: 35
Clinical Features of Scleritis Across the Asia-Pacific Region
Joshua Lane, Ethan Nyugen, Julie Morrison, et al.
Ocular Immunology and Inflammation (2018) Vol. 27, Iss. 6, pp. 920-926
Closed Access | Times Cited: 33
Ocular Emergencies
Andreina Tarff, Ashley Behrens
Medical Clinics of North America (2017) Vol. 101, Iss. 3, pp. 615-639
Closed Access | Times Cited: 32
Flurbiprofen: A Nonselective Cyclooxygenase (COX) Inhibitor for Treatment of Noninfectious, Non-necrotizing Anterior Scleritis
Rupesh Agrawal, Cecilia S. Lee, J.J. González‐López, et al.
Ocular Immunology and Inflammation (2015) Vol. 24, Iss. 1, pp. 35-42
Open Access | Times Cited: 30
Nanomedicine for immunosuppressive therapy: achievements in pre-clinical and clinical research
Hanan Al-Lawati, Hamidreza Montazeri Aliabadi, Behzad Sharif Makhmalzadeh, et al.
Expert Opinion on Drug Delivery (2017) Vol. 15, Iss. 4, pp. 397-418
Closed Access | Times Cited: 26
Diagnosis and management of non-infectious immune-mediated scleritis: current status and future prospects
Merih Oray, Halea Meese, C. Stephen Foster
Expert Review of Clinical Immunology (2016) Vol. 12, Iss. 8, pp. 827-837
Closed Access | Times Cited: 25
Ocular Pharmacology for Scleritis: Review of Treatment and a Practical Perspective
Maxwell S. Stem, Bozho Todorich, J. Lisa
Journal of Ocular Pharmacology and Therapeutics (2017) Vol. 33, Iss. 4, pp. 240-246
Closed Access | Times Cited: 25
Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review
Jurgen Sota, Matteo-Maria Girolamo, Bruno Frediani, et al.
Ophthalmology and Therapy (2021) Vol. 10, Iss. 4, pp. 777-813
Open Access | Times Cited: 19
Optimization and Characterization of Aqueous Micellar Formulations for Ocular Delivery of an Antifungal Drug, Posaconazole
Meltem Ezgi Durgun, Emine Kahraman, Sevgi Güngör, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 14, pp. 1543-1555
Closed Access | Times Cited: 19
Polymeric micelles as a novel carrier for ocular drug delivery
Yıldız Özsoy, Sevgi Güngör, Emine Kahraman, et al.
Elsevier eBooks (2019), pp. 85-117
Closed Access | Times Cited: 18
Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options
J. Daniel Lafreniere, Michael E. Kelly
Neuronal Signaling (2018) Vol. 2, Iss. 4
Open Access | Times Cited: 13
Pediatric Scleritis: An Update
Maria Tarsia, Carla Gaggiano, Elisa Gessaroli, et al.
Ocular Immunology and Inflammation (2022) Vol. 31, Iss. 1, pp. 175-184
Closed Access | Times Cited: 7
Rare within rare. Necrotising scleritis and peripheral ulcerative keratitis: eye-threatening complications of relapsing polychondritis
Laura Damian, Cristina Pamfil, Camelia Bucșa, et al.
Clinical and Experimental Rheumatology (2022) Vol. 40, Iss. 5, pp. 86-92
Open Access | Times Cited: 7
Measurements of scleral thickness and corneal optic densitometry in patients with systemic lupus erythematosus
Hüseyin Kaya, Uğur Karasu, Çiğdem Martin, et al.
Medicine (2020) Vol. 99, Iss. 31, pp. e21467-e21467
Open Access | Times Cited: 9
Sclérites et maladies systémiques : que doit savoir l’interniste ?
P. Bielefeld, David Saadoun, Emmanuel Héron, et al.
La Revue de Médecine Interne (2018) Vol. 39, Iss. 9, pp. 711-720
Closed Access | Times Cited: 9
Ocular involvement and complications of lichen planus, lichen planus pigmentosus, and lichen planopilaris: A comprehensive review
Raúl E. Ruiz-Lozano, Julio C. Hernández‐Camarena, Jorge E. Valdez-García, et al.
Dermatologic Therapy (2021) Vol. 34, Iss. 6
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top